Cat. #151066
Anti-Blood group A sugar determinant [9A]
Cat. #: 151066
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 1-2 weeks
Target: Blood group A sugar determinant
Class: Monoclonal
Application: FACS ; ELISA ; IHC ; IP
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Peter Parker
Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-Blood group A sugar determinant [9A]
- Clone: 9A
- Tool type ecom: Antibodies
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 52 kDa
- Reactivity: Human
- Host: Mouse
- Application: FACS ; ELISA ; IHC ; IP
- Description: 9A is suitable for binding to the EGF receptor in A431 cells only.
- Immunogen: A431 cells (human vulval squamous carcinoma cell line)
- Isotype: IgG3
- Myeloma used: P3X63Ag8
Target Details
- Target: Blood group A sugar determinant
- Molecular weight: 52 kDa
- Target background: 9A is suitable for binding to the EGF receptor in A431 cells only. These cells have a glycosylation defect which reveals otherwise cryptic sugar structures.
Applications
- Application: FACS ; ELISA ; IHC ; IP
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Increased a-series gangliosides positively regulate leptin/Ob receptor-mediated signals in hypothalamus of GD3 synthase-deficient mice.
- Fischer et al. 2015. Front Immunol. 6:211. PMID: 25999949.
- Gullick et al. 1990. J Pathol. 162(3):275-6. PMID: 2266467.
- 'EGF receptor' antibody 29.1.1.
- Parker et al. 1984. J Biol Chem. 259(15):9906-12. PMID: 6086658.
- Monoclonal antibodies against the human epidermal growth factor receptor from A431 cells. Isolation, characterization, and use in the purification of active epidermal growth factor receptor.
